How optimized LLMs are transforming drug development

Large Language Models (LLMs) are transforming drug development by accelerating research, improving decision-making, and enhancing efficiencies across various process stages. However, to fully harness their potential, LLMs must be optimized for specific use cases and tailored to the unique needs of pharmaceutical organizations.

Watch this session to discover how optimized LLMs can transform drug discovery, clinical trials, and regulatory processes by:

• Reduce time to market by streamlining research and data analysis
• Improve accuracy and compliance through tailored AI models
• Enhance collaboration across research, clinical, and regulatory teams

You’ll learn best practices for integrating LLMs into pharmaceutical workflows, ensuring compliance with regulatory frameworks, and optimizing AI models to drive innovation. Discover how leading organizations are leveraging AI to gain a competitive edge while maintaining efficiency and compliance.